Discover
DWTX
Dogwood Therapeutics, Inc.
2.15
1 x 2.11
1 x 2.15
bid
ask
+
0.17
8.59%
1 @ 04:00 PM
2.12 -0.03 (1.40%)
| Ytd | -48.32% | |
| 1y | -56.30% |
1.83
day range
2.15
1.34
52 week range
7.91
| Open | 1.97 | Prev Close | 1.98 | Low | 1.83 | High | 2.15 | Mkt Cap | 72.30M |
| Vol | 105.80K | Avg Vol | 71.56K | EPS | -10.60 | P/E | -0.20 | Forward P/E | -0.43 |
| Beta | 1.71 | Short Ratio | 0.42 | Inst. Own | 3.24% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 1.56 | 200-d Avg | 2.99 | 1yr Est | 13.83 |
DWTX News
globenewswire.com
Dogwood Therapeutics Announces Second Quarter 2026 Financial Results
- Halneuron ® Phase 2b trial in Chemotherapy Induced Neuropathy on track for top-line results in fal
benzinga.com
Dogwood Therapeutics Admits First 200 Participants In Its Current HAL-CINP Phase 2b Study To Evaluat
Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the "Company"), a development-stage biotechnology
benzinga.com
Earnings Scheduled For May 14, 2026
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket